Table 6.
Effect of Risk Factors on Extremity Dysfunction (Per Protocol Analysis)
| Primary and/or secondary radial access | Male sex | Female sex | P value |
|---|---|---|---|
| QD MCID ≥14, n (%) | 8 (5%) | 3 (9%) | 0.40 |
| QD MCID ≥8, n (%) | 13 (7%) | 7 (20%) | 0.05 |
| VAS discharge, median (IQR) | 2 (1–3) | 3 (2–5) | N/A |
| VAS follow‐up, median (IQR) | 2 (2–3) | 4.5 (4–5) | N/A |
| Primary and/or secondary femoral access | Male sex | Female sex | |
|---|---|---|---|
| LEFS MCID ≥9, n (%) | 17 (10%) | 6 (13%) | 0.41 |
| LEFS MCID ≥12, n (%) | 12 (7%) | 6 (13%) | 0.22 |
| VAS discharge, median (IQR) | 3.5 (2–5) | 3.5 (2–6) | 0.67 |
| VAS follow‐up, median (IQR) | 2 (2–3) | 2 (1–4) | 0.95 |
| Primary and/or secondary radial access | RAS | No RAS | |
|---|---|---|---|
| QD MCID ≥14, n (%) | 0 (0%) | 11 (6%) | 1.0 |
| QD MCID ≥8, n (%) | 2 (15%) | 18 (9%) | 0.36 |
| VAS discharge, median (IQR) | 3 (1–3) | 2 (1–5) | 1.0 |
| VAS follow‐up, median (IQR) | 4.5 (4–5) | 2 (2–3) | 0.09 |
| Primary and/or secondary radial access | Ultrasound guided | Not ultrasound guided | |
|---|---|---|---|
| QD MCID ≥14, n (%) | 0 (0%) | 11 (6%) | 1.0 |
| QD MCID ≥8, n (%) | 1 (7%) | 19 (10%) | 1.0 |
| VAS discharge, median (IQR) | 1.5 (1–5) | 2.5 (1.5–3) | 0.53 |
| VAS follow‐up, median (IQR) | N/A | 2.5 (2–4) | N/A |
| Primary and/or secondary femoral access | Ultrasound guided | Not ultrasound guided | |
|---|---|---|---|
| LEFS MCID ≥9, n (%) | 9 (10%) | 14 (11%) | 0.90 |
| LEFS MCID ≥12, n (%) | 6 (7%) | 12 (9%) | 0.53 |
| VAS discharge, median (IQR) | 2 (1–3) | 4 (4–6) | 0.008 |
| VAS follow‐up, median (IQR) | 2 (2–3) | 2.5 (1–3.5) | 1.0 |
IQR indicates interquartile range; LEFS, Lower Extremity Functional Scale; MCID, minimal clinically important difference; N/A, not available (not enough data); QD, Quick Disabilities of Arm, Shoulder, and Hand; RAS, radial artery spasm; and VAS, visual analog scale.